Prices vary by seller. Of the 14 sellers publishing both an injection and oral semaglutide, 8 list a higher price for the oral product. The median oral price minus the injection price is $34 per month.
The paired result
14 sellers on this desk publish a figure for both compounded semaglutide by injection and an oral semaglutide. That is a subset of the market mapped in the full price distribution. Of those, 8 price the tablet higher — 57% of the paired set. The median difference is $34 per month.
The tirzepatide sample is smaller. 5 sellers publish both formats and 2 charge more for the tablet. The median difference is $0.
What to compare in each quote
Ask what form the prescription takes and how much medication ships. The guide to advertised and billed prices explains how membership and program fees can change the total. Confirm the refill price for the same supply period before comparing the quotes.
Some oral listings are lozenges or dissolving tablets. The review of sublingual semaglutide evidence explains the limits of comparing these products with injections. Our guide to products sold as GLP-1 patches reviews the evidence for another delivery route. Ask your clinician about the specific formulation before using a price comparison to choose between products.
For orforglipron, use the Foundayo buying guide to compare prescription, care and refill charges. It covers a different medicine from the semaglutide pairs above.
Checking a specific pair
The head-to-head pages show how individual providers describe their offers. And the six-month totals show what each choice compounds to. Figures are computed from this site’s own price records at build time, most recently read November 2026.
The Direct Meds review describes an injection starter shipment with installment payments. Check how much medication an oral quote covers before comparing the two. The Wellorithm review documents the published injection renewal schedule. Ask for a written tablet quote with its supply period and renewal terms before comparing it with the injection.
What the research measured
A cost-plus model estimated potential generic prices after patent expiry at $28 to $140 per person-year for injectable semaglutide and $186 to $380 for the oral doses it modeled[1]. It included assumptions about formulation, packaging, taxes and margins. The estimates describe potential generic supply costs rather than the telehealth quotes above.
A Novo Nordisk-funded analysis used placebo as the common comparator across OASIS 4 and STEP 1 to estimate weight loss with oral semaglutide 25 mg and injectable semaglutide 2.4 mg[2]. In the indirect comparison, the treatment-regimen estimate favored the injection by 1.01 percentage points, with a 95% confidence interval of −1.61 to 3.63. The analysis did not evaluate the compounded oral products in our price records.
Prices vary by seller. The paired price breakdownshows how many sellers list the oral product at a higher, lower, or equal price.